Prepare for the American Board of Psychiatry and Neurology (ABPN) MOC Exam and fulfill MOC Requirements with over 1,600 Psychiatry Board Exam Questions. Earn up to 40.00 AMA PRA Category 1 CME Credit(s)™ and 40 ABPN MOC points, including the hard to find Self Assessment (SA) points, quickly and easily with just one activity.
Features Developed by top faculty and practicing physicians, BoardVitals helps thousands of doctors prepare for board certification exams and complete their CME requirements. BoardVitals is trusted by leading medical institutions including Harvard, Yale, Mt. Sinai, and Duke.
"This has been hands down the easiest way to earn Psych CME hours. I prepared for my exams while knocking out the hours requirement. Great qbank!" S. Paul, MD, Child and Adolescent Psych, Florida Sample Psychiatry Questions Question 1
Patients taking Selegiline may test urine positive for which drug?
A.) benzodiazepine
B.) methamphetamine
C.) marijuana
D.) cocaine
E.) opiate
Answer
B.) methamphetamine
Explanation
The correct answer is B. Selegiline is metabolized by the body into lmethamphetamine and lamphetamine, and a package insert is meant to alert users that this is a likely side effect of being on this drug. If they test positive for the other drugs on the list, it is more likely a positive drug test. Selegiline is a substituted phenethylamine used for the treatment of earlystage Parkinson's disease, depression and dementia. In normal clinical doses it is a selective irreversible MAOB inhibitor. However, in larger doses it loses its specificity and also inhibits MAOA.
Reference
Joska JA and Stein DJ. “Chapter 11: Mood Disorders” in The American Psychiatric Publishing Textbook of Psychiatry, 5th Ed. Hales RE, Yudofsky SC, Gabbard GO, editors. American Psychiatric Publishing, 2011
This question was taken from BoardVitals Psychiatry CME Question Bank
Question 2
A health care provider learns from a mutual acquaintance that a former patient who was treated for opioid addiction 5 years previously has completed medical school and entered a residency program. They last saw the patient 4 years ago, at which time the patient was compliant with treatment. Which of the following is true?
A.) Breach confidentiality and report the health care provider to the medical board
B.) Contact the health care provider assistance program in the former patient’s state and
reveal the history of drug abuse
C.) Without evidence that the former patient is impaired, you should not breach
confidentiality
D.) Contact the former patient and request evidence of compliance with treatment
E.) You have a legal duty to inform a responsible authority about the former patient’s
potential impairment
Answer
C.) Without evidence that the former patient is impaired, you should not breach confidentiality
Explanation
Correct answer: (C) Without evidence that the former patient is impaired, you should not breach confidentiality. Explanation: Although impairment may result from the use of psychoactive agents or illness, the presence of a disorder does not necessarily imply impairment. Unless a health care provider seems to be impaired now, there is no legal or ethical duty to report the health care provider based on history. Unless
there is evidence of current impairment or patient danger, a patient who is happens to be a health care provider has the same rights to confidentiality under the provider patient
relationship. When a health care provider identifies an impaired health care provider, there is a clear ethical duty to protect the patients of the impaired health care provider by reporting to an appropriate authority, although the legal responsibility to report an impaired health care provider varies among from state to state.
Reference
https://www.acponline.org/running_practice/ethics/manual/manual6th.htm#medicalrisk
This question was taken from BoardVitals Psychiatry CME Question Bank
Categories Covered in Course | Mental Retardation Learning Disorders Communication Disorders Autistic Disorder Rett's Disorder Childhood Disintegrative Disorder Asperger's Disorder ADHD Conduct Disorder Oppositional Defiant Disorder Feeding Disorders of Infancy/Childhood Tic Disorders Other Child/Adolescent Disorders Delirium Dementia Amnesic Disorders Alcohol-Related Disorders Amphetamine-Related Disorders Caffeine-Related Disorders Cannabis-Related Disorders Cocaine-Related Disorders Hallucinogen-Related Disorders Inhalant-Related Disorders | Nicotine-Related Disorders Opioid-Related Disorders Other Substance-Related Disorders Schizophrenia Schizophreniform Disorder Schizoaffective Disorder Delusional Disorder Major Depression Dysthymic Disorder Bipolar I Disorder Bipolar II Disorder Cyclothymic Disorder Other Mood Disorders Panic Disorder and Agoraphobia Specific Phobia Social Phobia OCD PTSD Generalized Anxiety Disorder Acute Stress Disorder Other Anxiety Disorders Somatization Disorder Conversion Disorder | Other Somatoform and Pain Disorders Anorexia Bulimia Sleep Disorders Basic Neuroscience and Neural Development Other Neurological Disorders Diagnostic Procedures in Neurology Evaluation of Neurologic Disorders Treatment of Neurological Disorders Psychopharmacology-Antipsychotics Psychopharmacology-Antidepressants Psychopharmacology-Anxiolytics Psychopharmacology-Sleep/Wake Medications Psychopharmacology-ADHD Medications Psychopharmacology-Dementia Medications Psychopharmacology-Substance Abuse Medications Psychopharmacology-Somatoform and Pain Medications Complementary and Alternative Therapies | |
